Nuvation Bio Inc. NUVB
4.06 USD -0.24 (-5.48%)
Nov 12, 2026, 1:11 PM EST
4.05 Day range 4.22
3.98 52-week range 9.75
- YTD
- -54.74%
- 1 year
- -17.75%
NUVB revenue history
Revenue is income from the company’s ordinary business activities.
62,902,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 62,902,000 | 55,029,000 | 698.96% |
| FY 2024 | 2024-12-31 | 7,873,000 | 7,873,000 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | 0 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | 0 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-05T11:05:33.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.